Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127860952 | 12786095 | 2 | F | 20160919 | 20160927 | 20160930 | EXP | US-PFIZER INC-2016423037 | PFIZER | 45.00 | YR | F | Y | 0.00000 | 20160930 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127860952 | 12786095 | 1 | PS | INLYTA | AXITINIB | 1 | Oral | 5 MG, 2X/DAY (TAKE 1 TABLET BY ORAL ROUTE EVERY 12 HOURS WITH A FULL GLASS (8 OZ) WATER) | U | 202324 | 5 | MG | FILM-COATED TABLET | BID | |||||
| 127860952 | 12786095 | 2 | SS | ALDACTONE | SPIRONOLACTONE | 1 | Oral | 50 MG, DAILY | U | 12151 | 50 | MG | TABLET | ||||||
| 127860952 | 12786095 | 3 | SS | ZYRTEC | CETIRIZINE HYDROCHLORIDE | 1 | Oral | 10 MG, 1X/DAY | U | 0 | 10 | MG | CAPSULE | QD | |||||
| 127860952 | 12786095 | 4 | C | ZOFRAN | ONDANSETRON HYDROCHLORIDE | 1 | Oral | 4 MG, 3X/DAY (EVERY 8 HOURS AND PLACE ON TOP OF THE TONGUE WHERE IT WILL DISSOLVE, THEN SWALLOW) | 0 | 4 | MG | DISPERSIBLE TABLET | TID | ||||||
| 127860952 | 12786095 | 5 | C | CLONAZEPAM. | CLONAZEPAM | 1 | Oral | 2 MG, 3X/DAY | 0 | 2 | MG | TABLET | TID | ||||||
| 127860952 | 12786095 | 6 | C | METOLAZONE. | METOLAZONE | 1 | Oral | 1.25 MG, DAILY (TAKE 1/2 TABLET BY ORAL ROUTE EVERY DAY) | 0 | 1.25 | MG | TABLET | |||||||
| 127860952 | 12786095 | 7 | C | METOPROLOL SUCCINATE. | METOPROLOL SUCCINATE | 1 | Oral | 100 MG, 2X/DAY (2 TABLETS) | 0 | 100 | MG | MODIFIED-RELEASE TABLET | BID | ||||||
| 127860952 | 12786095 | 8 | C | POTASSIUM CHLORIDE. | POTASSIUM CHLORIDE | 1 | Oral | 7.5 MILLILITER EVERY 3 DAYS DILUTED IN ONE- HALF GLASS (120 ML) OF COLD WATER | 0 | ORAL LIQUID | |||||||||
| 127860952 | 12786095 | 9 | C | TORSEMIDE. | TORSEMIDE | 1 | 100 MG, DAILY | 0 | 100 | MG | TABLET | ||||||||
| 127860952 | 12786095 | 10 | C | TRAZODONE | TRAZODONE HYDROCHLORIDE | 1 | Oral | 50 MG, 3X/DAY (TAKE 1 TABLET BY ORAL ROUTE 3 TIMES EVERY DAY AFTER MEALS) | 0 | 50 | MG | TABLET | TID | ||||||
| 127860952 | 12786095 | 11 | C | VITAMIN B12 | CYANOCOBALAMIN | 1 | 50 UG, UNK | 0 | 50 | UG | TABLET | ||||||||
| 127860952 | 12786095 | 12 | C | VITAMIN D3 | CHOLECALCIFEROL | 1 | 400 IU, UNK | 0 | 400 | IU | CAPSULE |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127860952 | 12786095 | 1 | Hereditary haemorrhagic telangiectasia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127860952 | 12786095 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127860952 | 12786095 | Cardiac failure | |
| 127860952 | 12786095 | Diarrhoea | |
| 127860952 | 12786095 | Hypokalaemia | |
| 127860952 | 12786095 | Product use issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |